Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:50 PM
Ignite Modification Date:
2025-12-24 @ 11:50 PM
NCT ID:
NCT00998751
Eligibility Criteria:
Inclusion Criteria:
* Male or Female patients, age \>18
* Life expectancy \> 6 months
* Histological proven, metastatic, or locally advanced and non-operable, non- pre-treated GIST.
* Patients having never received any tyrosine kinase inhibitor, including as adjuvant therapy
* C-Kit (CD117) positive tumors detected immuno-histochemically
* Measurable tumor lesions with longest diameter \>20 mm using conventional techniques or \>10 mm with spiral CT scan
Exclusion Criteria:
* Documented allergy to the similar drug of AB1010
* Inadequate organ function
* Patients with a history of any other malignancy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00998751
Study Brief:
Protocol Section:
NCT00998751